Here, we present a protocol to visualize and standardize resazurin microtiter assay (REMA) and its checkerboard variation for evaluating the drug susceptibility and interaction profiles of Mycobacterium tuberculosis. This method provides insights, in vitro, for optimizing drug combinations to be used in treatment regimens and combating multidrug-resistant tuberculosis.
